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Clotting Phenomena at the Blood-Polymer Interface 
and Development of Blood Compatible Polymeric 
Surfaces 
Adriaan Bantjes 
In the past two decades many attempts have been made t o  relate surface and interfacial 
parameters with the blood compatibility of polymeric surfaces. It is however doubtful 
if by a single parameter the behaviour of blood on a surface can be predicted. Two major 
aspects of blood compatibility -- the prevention of platelet adhesion and the deactivation 
of the intrinsic coagulation system are determined by the measure and nature of competi- 
tive blood protein adsorption on the foreign surface. The adhesion of blood platelets is 
promoted by adsorbed fibrinogen and gamma globulin, while adsorbed albumin inhibits 
platelct adhesion. Heparinised surfaces d o  not adsorb fibrin and consequently no adhesion 
of platelets takes place. Othcr surfaces with low platelct adhesion are the hydrogels, 
certain block copolyetherurethanes, polyelectrolyte complexes and biolised proteins. 
Heparinised surfaces of the cationically bonded type inhibit the intrinsic coagulation as 
well, however this may be due to  unstable coatings and heparin leakage. 
In the authors laboratory a synthetic heparinoid was prepared with the structure 
- [CH, - C(CH3)  NHS03Na ~ C(H) COONa ~ CH2 --] 
with h, = (7 .5  5 1 .O)  x lo5 and an in v i v o  anticoagulant activity of 50% of heparin. Its 
coatings on PVC, using tridodecyltiietliyl-ammoniuni chloridc as a coupling agent, are 
stable in plasma and salt solutions and provide surfaces which show negligible platelet 
adhesion and a strong inhibition 0 1  the intrinsic coagulation on contact with blood. Similar 
results were found with polydimethylsiloxane surfaces coated with this heparinoid. 
1. INTRODUCTION 
The clinical use of blood contacting devices and prosthcses is 
of major importance today in cardiovascular surgery and 
other fields of medicine. Heart valve ~ and blood vesscl 
prostheses, balloon pumps, and catheters are being implanted 
in daily surgical practice t o  restore or diagnose carhovascular 
function. Artificial organs are routinely employed in blood 
dlalysis (artificial kidney), in blood detoxification by ad- 
sorptive haemopcrfusion and in oxygenation (membrane 
oxygenators and heart-lung devices). Considerable effort 
and capital is invested in Europe and the USA in the dcvclop- 
ment and experimental evaluation of an implantable artifi- 
cial heart system. These devices are generally constructed 
from polymeric materials and when in use a blood-polymer 
contact is present. TIUS contact will cause a reaction in the 
recirculating blood, w h c h ,  depending on the materials 
choice, the design parameters, the flow or the addition of 
anticoagulants may lead t o  protein deposition, adhesion and 
destruction of red blood cells (haemolysis), platelet (throm- 
bocyte) adhesion and aggregation and blood coagulation 
leading to  the formation of a haemostatic plug (thrombus) 
(Fig. 1). The occurrence of thromboembolism in cardtovas- 
cular surgery continues t o  be a problem, notwithstanding 
routine treatment with anticoagulants. For these reasons 
the search for blood compatible nonthrombogenic materials 
has been an important research objective over the last two 
For  a perception of the routes along which 
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new blood compatible materials may be developed it is 
necessary t o  explain sotne of the mechanisms of blood co- 
agulation on intcraction with a foreign surface. 
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I'ig. 1 Blood-l'orcign surfacc contact phcnonicna. 
1.1 Protein adsorption 
The very first event on blood-polymer surface contact is a 
rapid adsorption of plasma proteins from the blood onto 
the material surface. Upon adsorption of plasma proteins 
the material surface will be altered and the subsequent events 
will be determined by the modified surface. The relation 
between the character of the polymeric surface and the rate 
of protein adsorption and the composition and thickness of 
THE BRITISH POLYMER JOURNAL, VOLUME 10, DECEMBER 1978 267 
the adsorbed protein layer is today largely unknown, notwith- 
standing the numerous research reports and publications in 
this area.4-6 Protein adsorption generally follows a Langmuir 
adsorption and hydrophobic surfaces interact more 
strongly with proteins9 and adsorb more protein than hydro- 
philic  surface^.^ Generally hydrophobic surfaces adsorb 
proteins irreversibly.1° There are strong indcations that 
preferential adsorption of  one type of  blood protein over 
another may play an important role in the sequential events 
- platelet adhesion and coagulation. Many polymers adsorb 
fibrinogen rapidly," which in its turn can promote the 
adhesion of blood platelets.' 2-14 For certain block copoly- 
etherurethanes it was reported that a high and specific albu- 
min adsorption determines its high blood compatibility.' 
Heparin coated surfaces do not adsorb fibrinogen and plate- 
lets do not adhere on these surfaces.16-18 Although a number 
of authors report on competitive adsorption studies with 
radiolabelled  protein^,^^,^^ more work is necessary t o  obtain 
necessary insight in the first phase of the blood coagulation. 
In the authors laboratory a study indicated that one should 
be extremely careful in the selection of the radiolabelled 
proteins.21 Several procedures for labelling proteins resulted 
in unstable labels, but even stable 99n1Tc and 1 2 5 1  labelled 
sei-um albumin showed preferential adsorption over unlabelled 
albumin. For better understanding of blood coagulation the 
work on competitive adsorption of blood proteins should 
continue but with biologically produced radiolabelled starting 
materials where the danger of preferential adsorption is 
niinimise d. 
Fig. 2 gives a schematic sequence of events following the 
protein adsorption, which are described below in inore detail. 
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1. Exposure of blood to  a foreikm material 
2. Adsorption of proteins from the blood onto the foreign material. 
3. Adhesion of platelets to the adsorbed protein layer. 
4. Release of ADP and othcr platelet constitutcnts. ]:ormation o f a  
platelet aggregate. 
5. The coagulation process is started on the surface of the aggregating 
platelets. Formation of an insoluble fibrin network. 
6. Individual platelets lose their intcgrity and fuse with each other. 
1,'ibrin strands with entrapped cells from the blood form a red 
thrombus. 
Interaction of a foreign material with blood. 
4a Formation of a white thrombus by aggrcgating platelets. 
l a  The coagulation process is started by activation of factor XI1 on 
I b  Thrombin is formed during the coagulation process, resulting in 
thc foreign surface. 
platelet asregation. 
1.2 Platelet adhesion and aggregation22 ,23 
The adhesion of thrombocytes on  a polymer surface is pre- 
sumably caused by the formation of an enzyme-substrate 
complex between the enzyme glycosyl transferase on the 
thrombocyte's surface and heterosaccharides of the adsorbed 
glycoproteins fibrinogen and gamma g l ~ b u l i n . ~ . ~ ~  Sugar 
nucleotides can then be transferred from the platelet t o  the 
protein. This is no t  possible with albumin as i t  is a pure 
protein and saccharide chains are not  present here. This 
adhesion mechanism is similar t o  that suggested for the inter- 
action of platelets with collagen in case of damage to  the 
wall of a blood-vesseLZ After adhesion the platelets show 
tentacle like protrusions, the pseudopods; they then con- 
tract and undergo the release reaction, whereby adenosine di- 
phosphate (ADP), serotonine and other substances are freed. 
ADP causes more platelets to  stick t o  those already adhering. 
Thus platelet aggregation takes place as an autocatalytic 
process. In a still later phase the platelet aggregates undergo 
'viscous metamorphosis', fusion into a homogeneous w h t e  
thrombus. When at the thrombocyte surface enzymatic 
coagulation factors are activated the result will be a red 
thrombus, built up  of fibrin fibres, platelets, red cells and 
other blood components. When anticoagulants are present 
fibrin is not  forined and only a white thrombus forms as 
has been observed in arterial-venous shunts under conditions 
of h e p a r i n i ~ a t i o n . ~ ~  
1.3 Intrinsic coagulation 
Intrinsic coagulation is a complicated process of a number of 
reactions occurring mainly between soluble proteins in blood 
or plasma. The final step is the conversion of soluble fibri- 
nogen into insoluble fibrin fibres. The proteins ale called 
coagulation factors. Table 1 summarizes the accepted 
Roman numerals and synonyms for these factors. Factors 
converted t o  their enzymatically active form are indicated 
with a suffix below the Roman numeral. The coagulation 
schema given by Fig. 3 is based on recent data28 and shows 
the sequential activation of the factors in a 'cascade mech- 
anism'. The coagulation is set in motion by activation of 
factor XI1, the Hageman factor, through adsorption on a 
foreign surface. The activated factor XI1 (XIla) activates 
factor XI on the surface proteolytically. Calcium ions 
play an important part in the activation of a number of 
factors. The coagulation process and the adhesion and aggre- 
gation of platelets proceed independently although in the 
later phases of platelet aggregation interaction with the 
blood coagulation may occur. 
The influence of flow conditions on platelet adhesion and 
intrinsic coagulation are not  dealt with here, but are de- 
scribed elsewhere. 8a 
1.4 Anticoagulation 
T o  prevent coagulation direct or indirect anticoagulants are 
used. The latter type prevents the biosynthesis of some 
coagulation factors. An example is 4-hydroxy coumarin. A 
direct anticoagulant is lieparin29.30 (see Fig. 4), a niuco 
polysaccharide carrying sulphate, sulphamate and carboxylate 
groups. Depending on its natural source its &t, may vary 
from 8-20,000. Its activity is based on the catalytic acti- 
vation by heparin of antithrombin 111, the heparin cofactor, 
which is present in the blood. Activated AT 111 forms com- 
plexes with thrombin31132 and also with the activated 
factors VIIa,33 IXa,34 Xa35 and XIa,36 thus inhibiting co- 
agulation and fibrin formation. Heparin does not  occur 
freely in the blood, but  it is present in the blood-vessel w a l l ~ . ~ ~ - j '  
Its half-life in the body is around 1.5 hours.40 The molecular 
basis for the anticoagulant activity is no t  very well understood. 
Other naturally occurring sulphated polysaccharides are con- 
siderably less or not  at all a ~ t i v e . ~ l - ~ ~  However the presence 
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and level of sulphamate g r o ~ p s ~ ~ - ~ ~  is of essence for its 
activity, which also depends on the molecular46 weight. 
Table 1. Coagulation Factors 
number name synonyms 
I 
prothrombin thrombin ---------------- 
( 1 1 )  i CaZ + 
f i n r i n o g e n L  fibrin monomers 
I 
1 
fibrin polymers 
2. BLOOD COMPATIBLE MATERIALS 
For the correlation with blood-surface interaction phenomena 
a number of  parameters were suggested - surface and inter- 
facial parameters, surface charge and ( potential, conductivity 
and domain structure. 
I 
II 
I l l  
IV 
V 
VI 
VI  I  
V l l l  
I X  
X 
XI 
X I  I 
X l l l  
fibrinogen 
prothrom bin 
t h rom bo p I as t i n 
calcium ion 
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fibrin stabilising 
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Fig.4 The structure of heparin. 
2.1 Surface and interfacial parameters4’ 
A first attempt t o  relate surface properties with bood com- 
patibility dates from 1930.48 It was stated that clotting 
time was inversely proportional t o  the wettability of a surface. 
It is however generally incorrect t o  state that a hydrophobic 
surface is less thronibogenic than a hydrophilic one. Much 
later surface free energy or surface tension, defined as 
y =  F-FYA 
( F =  free energy of the bulk, F ’ =  free energy of 
the surface, A = surface area), was considered as a criterion 
for blood c o t i i p a t i b i l i ~ y . ~ ~ . ~ ~  It is more logical t o  consider 
the interface of the polymer with blood, and the interfacial 
free energy defined as y s L  = ys - yslLl + y~ - y ~ l s l  has 
been considered as a para i i i~ te r .~’  
(ys and yL are the surface tensions of  the solid and liquid 
respectively and ysl and yLls1 express the effect of one 
phase upon another). 
When a drop of  liquid is placed on a surface the equilibrium 
spreading of  the liquid is given by the Young-Dupre relation: 
(0 = contact angle, the interfacial tensions are given by ysv 
(solid vapour), ysL (solid-liquid) and yLv (liquid vapour). 
From contact angle nieasuremcns the surface free energies 
of polymers were c a l c ~ l a t e d . ~ ~  These data were used later 
to generate data for the interfacial t e ~ i s i o n s , ~ ~ , ~ ~  but some
questionable assumptions make these data a t  best rough 
estimations. This notwithstanding, materials with a niininial 
interfacial energy like hydrogels d o  possess a low thrombo- 
adherence. Zisnian correlated the contact angle 0 with the 
yI, for the interface of the components of  a homologous 
series of liquids on polymers.% The empirical relation 
cos 0 = a-by, was found. 
The criticafsurjace tension yc,defincd as (a-l)/b or the value 
of yL for which 0 = 0 was also used as a parameter,ss though 
an inadequate one because of the dependence of yc on the 
series of liquids used.56 It must be doubted that by a single 
surface or interfacial parameter the behaviour o f  blood on a 
surface can be predicted. 
2.2 Surface 
Ysv = YSL -k YLV cos 0 
The blood-vessel wall has a negative ( potential of -8 t o  -13 
mV. s9 This surface charge may act by repulsion of negatively 
charged blood components such as cells and proteins. Elec- 
trets with a negative surface charge generally show better 
blood compatibility than the nonpolarised polynieric surface.60 
Not all negatively charged Golymer surfaces are antithrombo- 
genic; poly(styrene sulphonate) causes as much coagulation 
as polystyrene itself.61 Positively charged or polarised sur- 
faces are however generally thrombogenic.62 Interesting are 
the complexes of polycations with an excess of polyanions, 
which show antithrombogenic p r ~ p e r t i e s . ~ ~  
3. MATERIALS USED FOR BLOOD-CONTACT 
APPLICATIONS 
Common commercial polymers such as silicone rubbers, poly- 
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olefins, polyvinylchloride, polytetrafluorethylene, cellulosics, 
polyesters and polyanlides are thrombogenic and application 
of anticoagulants is indicated. Velours, knits and porous 
structures are used for prolonged periods as they are designed@ 
to trap clots and promote i n g r o ~ t h ~ ~  of fibroblastic and 
endothelial cells, thus producing a living surface which si- 
mulates the inner wall of the blood-vessels. Certain poly- 
urethanes, in particular the block copolyetherurethane urea 
type (PEUU)66*67 are built up of polypropyleneoxide or 
polytetramethyleneoxide (M.W. 1025) segments with meth- 
ylene (4-bis phenyl isocyanate) and aliphatic diamines such 
as ethylene diarnine as chain extenders. Another type, 
Avcothane, is a block copoly (dialkyl siloxane) urethane.68 
These polymers show remarkably good blood compatibility, 
due to their high albumin and low fibrinogen a d ~ o r p t i o n . ~ ~  
The underlying reasons for t h s  specific adsorption behaviour 
is poorly understood; the platelet adhesion is favourably 
affected by the types showing a minimal phase s e ~ a r a t i o n . ~ ~  
Their excellent flex properties and good solubility make these 
materials very suitable for the construction of artificial 
hearts.71 
Hydrogels are polymers which exhibit the ability to swell in 
water and retain more than 20% water withm its structure.72 
They provide a very low interfacial free energy system with 
water or blood. The best known types are poly(hydroxyethy1) 
methacrylate, polyacrylamide and copolymers containing 
poly(N-vinyl pyrrolidone-2). These types of polymer belong 
to thc most nonthromboardherent systems, but recent results 
with hydrogel grafted arterial-venous shunts indicate an 
increasing platelet destruction73 level with increasing water 
content in in vivo tests. 
Polyelectrolyte complexes are hydrogel-li ke combinations of 
polycations and polyanions. Complexes of poly(viny1 benzyl- 
trimethyl ammonium) chloride or poly(diallyldimethy1 
ammonium) chloride with a slight excess of sodium poly 
(styrene sulphonate), also known as I ~ p l e x e s , ~ ~ ~  show good 
antithronibogenicity. A general problem with all hydrogel 
polymers is their lack of mechanical strength. 
Albumin coated surfuces do not attract thrombocytes and 
have found succesfull clinical a p p l i ~ a t i o n . ~ ~  Preliminary in 
vitro experiments carried out in our laboratory indicate that 
the activation of the intrinsic coagulation is not purely de- 
pendent on the type of preadsorbed protein but also on the 
nature of the material. 
Riolized surfaces75 are generally composite structures of 
which a rough surfaced elastomeric material is treated with 
a solution of albumin or gelatin.76 Then a treatment with 
formaldehyde or glutaraldehyde is given to effect cross- 
linking. 
Heparinized surfuces are generally obtained by ionically 
linking of heparin to a polymer surface by means of quater- 
nary ammonium groups. These groups may be provided by 
low molecular weight  detergent^^^-'^ such as tridodecyl 
methyl ammonium chloride (TDMAC) or benzalkonium 
chloridea0 as coupling agents or they may be introduced 
chemically into the polymer or on the surface. An example 
is the grafting of sjyrene by radiation to various polymers 
and subsequent chloromethylation and amination.*' 
Heparinisation with TDMAC as a coupling agent may be 
carried out in two ways: 
(a) by a two step method where first TDMAC is brought into 
contact with the polymer in the presence of a swelling 
agent. After drying a second treatment follows with 
an aqueous solution of heparin to provide the final 
coating. 
(b) a one step method in which a TDMA-heparin complex 
is made and direct coating takes place from a complex 
solution in an organic solvent.82.83 
The final coating can be stabilised by crosslinking with glut- 
araldehyde s o l ~ t i o n . ~ ~ , ~ ~  Other methods for obtaining 
heparinised surfaces are: 
(a) mixing of heparin through the polymer before pro- 
c e s ~ i n g . ~ ~ , ~ ~  These surfaces show leakage of heparin 
after blood contact. 
(b) covalent bonding of heparin through radiation grafting88 
or reactive groups ( i ~ o c y a n a t e , ~ ~  cyanuric chloride).90 
Unfortunately the covalently attached heparin is much 
less active in preventing coagulation than the ionic 
complexes. 
groups.18 
(c) by using polymeric coupling agents with cationic linking 
The activity of heparinised surfaces rests on their capacity to 
bind and activate antithrombin 111 on the surface.32 Throm- 
bin is then neutralised by the bound antithrombin 111 and 
actually broken down so that heparin bound antithrombin 
111 becomes again available for renewed thrombin deactivation. 
This mechanism also applies to the deactivation of factors 
IXa, Xa and XIa.35 Fibrinogen adsorption from blood does 
not take place on these surfaces and platelets do not 
adhere.91,16,17 Some doubt exists concerning the stability 
of the ionically bonded heparine and several authors claim 
that leaching of heparin from the surface could well be the 
reason for the anticoagulant activity.8l ,90,92 
3.1 Heparinoid systems93 
In our laboratory a number of heparinoids have been syn- 
thesised by reaction of unsaturated polymers like poly(cis-I, 4 
isoprene)94 with the specific reagent N-chlorosulphonyl 
i s o ~ y a n a t e , ~ ~ , ~ ~  which adds to - 70% of the double bonds: 
CH,-C=CH-CH, + ClO,S-N=C=O --+ 
I 
The polymeric beta lactain sulphonyl chloride is then hydro- 
lyzed with a 2N sodium hydroxide solution to polyelectrolyte 
P 
1 
J 
P 
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For polyelectrolyte P the starting material was pharmaceutical 
grade poly(cis-1, 4 isoprene) Shell Cariflex 307), Mw : 2.4 x 
lo6). Polyelectrolyte P contains the same sulphamate and 
carboxylate groups we find in heparin, though no  sulphate 
groups are present. The product is a watersoluble, white 
crystalline material with a M w  of(7.5 x 1.0) x l o 5 .  It is a 
nontoxic and nonpyrogenic9 direct anticoagulant with an in 
vivo activity o f  50% that o f  h e p a r h g 8  
In many ways its activity is similar t o  that of heparin,99 with 
the exception o f  possessing a much stronger antipolynierase 
activity in the polymerisation of the fibrin monomer. Its 
biodegradation in vivo (rabbit tests) is similar but slightly 
slower than heparin itself. Contrary t o  heparin i t  will undergo 
gamma sterilisation without loss of  activity. The presence of 
both sulphaniate as well as carboxylate groups is essential 
for the anticoagulant activity. Acid cleavage of the N--S 
bond to an extent of 50% as well as substitution of the car- 
boxylate group by carbonamide resulted in loss of activity.Ioo 
A similar product synthesised front poIy (trans I ,  4-isoprcne), 
Polysar 1811,Mw : 4.3 x l o 6 ,  gave lui almost identical 
product, though configurationally differcnt, with an anti- 
coagulant activity of only half that of  polyelcctrolytc P. 
3.2 
complexes 
Coating of surfaces with polyelectrolyte P-TDMA 
In analogy with the TDMk-heparin coatings, onc and two step 
coatings were applied to PVC surfaces, substituting thc poly- 
electrolyte P for heparin. Thc PVC used was of a vet-y purc 
grade (Breon S1 l O / l O ,  Mw : 56000,M11 : 28000). Solvcnt 
swelling of PVC is nccessary for the uptake of TDMAC. An 
adsorption isotherm at 20" of TDMAC on PVC i n  tolucne 
was determined (Fig. 5). From thcsc da ta  and from thc 
dctcrmination of the fraction o f the  TDMAC on thc polymcr 
surface, which is capable of  36Cl- exchange, it becomes 
clear that most of the TDMAC is dissolved in the polynicr 
and only a fraction is available for ion exchangc (Tablc 2.) 
z 
D 
2 I- !:!
I 1 I 1 
0 0.02 0.04 
equilbrium concenttation (mole/l) 
I ifi.5 
aolution a t  2 0 T .  
Sorption lsotherm of TDMAC by I'VC trom tolucnc 
Table 2. Chloride exchange of TDMAC adsorbates with 
3 6 ~ 1 -  
To tal TDMA C presen t 
(i.imole/g PVCl tpmole/g P VCj 
Exchangeable C T  
4.247 0.051 5 
6.056 0.2167 
7.125 0.3051 
Little is known about the theory of polyelectrolyte adsorp- 
tion on a countercharged surface. One treatment exists 
however, which states that the number of adsorbed units 
reaches a saturation value when the polyelectrolyte con- 
centration increases.lol The number of  dangling chain 
segmentsiM (loops and tails) greatly increases near this 
saturation value of the number of  trains. So the ionic attach- 
ment of  the adsorbed layer decreases with increasing poly- 
electrolyte concentration. For overall adsorption and 
desorption studies the polyelectrolyte P was labelled with 
1251, using a modification of the Greenwood procedure.1a 
As in the complex formation for each ionic bond formed a 
chloride ion is freed, the number of adsorbed polymer seg- 
ments could be determined from the exchange of 
Table 3 gives the number of adsorbed polyelectrolyte seg- 
ments per molecule. Desorption experiments with lZs l  
labelled polyelectrolyte in saline solution (0.15 M) and 
bovine plasma showed irreversible adsorption of  the hepari- 
noid. The adsorbed layer can be described as a quasi solution 
where all molecules are linked t o  the surface through a 
number of  segments at all time. lo4 
Table 3. Determination of the number of adsorbed segments 
per polyelectrolyte molecule 
TDMAC/PVC adsorbed number of 
ion-exchange poly- released adsorbed seg- 
men ts per capacity elec troly tea chloride 
W d 9  Ped9 i.ieq/g molecule b 
0.051 5 3.9" 
14.1 
24.0 
46.3 
62.7 
0.2167 4.9 
14.4 
28.1 
36.4 
68.2 
3. 5" 
12.1 
28.6 
43.2 
78.4c 
0.3051 
0.034 34.4 
0.036 5.9 
0.039 3.3 
0.039 2.5 
0.096 77.4 
0.096 26.3 
0.095 13.4 
0.096 10.4 
0.094 5.4 
0.156 176.0 
0.1 55 50.6 
0.153 21.1 
0.153 14.0 
0.1 53 7.7 
0.035 9. a 
a From adsorption experiments with labeled polyelectrolyte 
b Assumed molecular weight of P : 750,000 
c Samples of this composition used for desorption experiments 
3.3 Blood contact properties of heparinoid coatings 
Coagulation cxperinients were carried out  by recalcification 
of plasma and whole blood in coated tubes a t  37". Results 
are given in Table 4 and 5, which indicate the nonthrombo- 
gcnicity of the coatings. Threshold values of between 8 and 
14 mg/m2 of the heparinoid seem to be required for non- 
thrombogenic behaviour. Platelet adhesion was measured 
in an ex vivo cell system based on the experimental approach 
of Mason et al. 105-107 A physiological salt solution is dis- 
placed from the cells by native blood in the absence o f  an 
air-blood interface. The blood is slowly pumped through a 
series of parallel flow cells of which one contains a reference 
material and the others the various test polymers in sheet 
form. An exploded view of the cell is given in Fig. 6. 
T H E  BRITISH POLYMER JOURNAL, VOLUME 10, DECEMBER 1978 27 1 
Table 4. Experiments with one-step coatings; bovine plasma 
~~~ 
clotting time clotting time after 
after transfer from test 
recalcification material to glass 
Material (min) (min) 
- glass 3 
PVC (uncoated) 12 - 
PVCITDM A-I?. 15-20 - 
PVCITDMA-P, X O  3 
methyl acetate 
washed 
PVCITDMA- heparin >60 >30 
Table 5. Experiments with two-step coatings; human plasma 
clotting time after 
TDMAC P bound recalcification transfer to glass 
eo/m2 m.q/m2 time (min) (min) 
0 0 12 
0.05 0.6 12-15 
7.4 12-1 5 
0.30 2.1 12-1 6 
14.8 > 60 
15.4 > 60 
23.7 > 60 
I’ig.6 Exploded view of a flow cell, based on the expcriincntal 
approach of Mason. 
1. Silastic rubber gasket, 3 min thick, with elhptical cut  out. The 
axis of the ellips are 6 3  and 24 mm. 
3 Inlet and outlet of the cell, consisting of cut off needles (Luer P), 
1.20 nun thick. 
3. Sheets of the matcrial to be tested. 
4. Lucite support blocks. The holcs in one support block are threaded 
internally; the other block has plain holes. 
The cell is assembled with the aid of four bolts. 
Platelet adhesion and fibrin deposition were studiedIo8 by 
scanning electron microscopy after glutaraldehyde fixation, 
rinsing and vacuum coating with a conducting layer of carbon 
and gold on the surfaces. Table 6 gives the results of  plate- 
let adhesion and PTT times. The heparinoid coated surfaces 
showed a very low platelet adhesion. In the very few plate- 
lets visible on the surface n o  pseudopods could be observed. 
Table 6. Adhesion of Platelets and Activation of Intrinsic 
Coagulation 
Adhering Platelets on PTT value in % 
Material 0.01 mm2 (PS = lOO”/,l 
glass 33-59 
polystyrene 13-21 
PVC 13-18 
PVCITDMA-P 1.5-3.0 
65 
100 
100 
103-113 
3.4 
Heparinised surfaces do not  adsorb fibrinogen. Due to the 
similarity with the heparinoid P coated surfaces we may 
assunie the absence of fibrinogen adsorption on these surfaces. 
This would explain the virtual absence of platelet adhesion 
here. The coatings show a hydrogel like structure with a 
relatively high water content and as such they may be non- 
thromboadheren t .  The absence of  coagulation can be con- 
nected with the anticoagulant activity of the heparinoid with 
the result that activation of antithrombin 111 takes place, 
followed by neutralisation of thrombin and other activated 
coagulation factors. In order t o  test t h s  the uptake of 
AT-I11 by polyelectrolyte P coated surfaces was 
TDMAC treated PVC powders were treated with solutions of  
heparinoid to  obtain coztings of w h c h  the composition was 
derived from the adsorption isotherm. The coated powders 
were shaken with plasma for one hour and the plasma was 
filtered t o  determine in the filtrate the AT-111 concentraiion. 
Then the treated powders were washed and shaken with a 
thrombin solution (5U/ml) .  AT-I11 was determined and 
expressed in thonibin neutralised units. The results of the 
AT-111 adsorption determinations and the thrombin neutra- 
lization are given in Fig. 7. The AT-111 adsorption is pro- 
portional to the surface concentration of the polyelectrolyte 
P, as is the subsequent neutralisation of thrombin. Minimum 
levels of around 10 nig/in2 are required for nonthrombo- 
genici t y . 
The nonthrombogenicity of surface bound heparinoid P 
151 
- 
m 
3 
. 
I 
9 10- 
/ 
thrornbogenic 
0 // 
surface concentration of P (mg/m2) 
Fig.7 
neutralization (A) by two step coatings of P on TDMAC/PVC. 
Antithrombin adsorption (0) and subsequent thrombin 
272 THE BRITISH POLYMER JOURNAL, VOLUME 10, DECEMBER 1978 
4. CONCLUSIONS AND FUTURE PERSPECTIVES 
A number of approaches have led t o  diverse blood compat- 
ible surfaces. What is lacking is a better fundamental in- 
sight in the processes involved in the interaction of the 
material and biological medium. A phenomenon such as the 
preferential adsorption of albumin on certain copolyether 
urethanes should be studied extensively, both from the 
materials as from the haeniatological and biochemical angles 
to obtain insight in the reasons for selective protein adsorp- 
tion, which may offer the key t o  a final solution t o  the blood 
compatibility problem. The minimal interfacial free energy 
concept, which has led to  nonthroniboadlierent hydrogcls, 
deserves further scrutiny, but need broader investigations 
in view of the recent discovery of higher platelet destruction 
with increasing gel water content. The field of  polymeric 
heparinoids is, as a part of  the field of polynieric drugs an 
open research area where advantages exist over routinely 
used anticoagulants such as heparin. The slow release of  
anticoagulants may offer improved opportunities for treat- 
ment. The effects of flow on blood compatibility are not 
extensively hiown, but research is carried out in many 
centres and also in the authors laboratory to  evaluate the 
combined effects of shear and materials contact on blood 
compatibility. 
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